Albany Molecular Research, Inc. (NASDAQ:AMRI)

CAPS Rating: 4 out of 5

The Company is a global chemistry-based drug discovery and development company focused on identifying and developing novel biologically active small molecules with applications in the drug market.

Recs

0
Player Avatar samlove (70.34) Submitted: 1/2/2008 1:52:56 PM : Outperform Start Price: $13.70 AMRI Score: -74.97

On a strictly technical basis, my magic charts say this will outperform the S&P

Featured Broker Partners


Advertisement